SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-064252
Filing Date
2017-12-06
Accepted
2017-12-06 18:21:54
Documents
1
Period of Report
2017-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4224
  Complete submission text file 0001209191-17-064252.txt   5739
Mailing Address C/O CANCER VAX CORP 2110 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address
PHILLIPS BARCLAY A (Reporting) CIK: 0001265801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 171243159

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences